XML 42 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Apr. 30, 2015
Apr. 30, 2014
Cash Flows from Operating Activities    
Net income $ 2,949us-gaap_NetIncomeLoss $ 1,652us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation 1,145us-gaap_Depreciation 864us-gaap_Depreciation
Amortization of intangible assets 892us-gaap_AmortizationOfIntangibleAssets 553us-gaap_AmortizationOfIntangibleAssets
Amortization of deferred financing costs 14us-gaap_AmortizationOfFinancingCosts 0us-gaap_AmortizationOfFinancingCosts
Accretion of contingent acquisition liability 128us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 0us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Provision for doubtful accounts receivable (35)us-gaap_ProvisionForDoubtfulAccounts 66us-gaap_ProvisionForDoubtfulAccounts
Stock-based compensation 567us-gaap_ShareBasedCompensation 807us-gaap_ShareBasedCompensation
Deferred income taxes (218)us-gaap_DeferredIncomeTaxExpenseBenefit 1,643us-gaap_DeferredIncomeTaxExpenseBenefit
Gain on sale 0us-gaap_GainLossOnDispositionOfAssets (9)us-gaap_GainLossOnDispositionOfAssets
(Increase) decrease in:    
Accounts receivable 1,019us-gaap_IncreaseDecreaseInAccountsReceivable (861)us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (323)us-gaap_IncreaseDecreaseInInventories (822)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses (322)us-gaap_IncreaseDecreaseInPrepaidExpense (581)us-gaap_IncreaseDecreaseInPrepaidExpense
Income taxes refundable 0us-gaap_IncreaseDecreaseInIncomeTaxesReceivable (282)us-gaap_IncreaseDecreaseInIncomeTaxesReceivable
Increase (decrease) in:    
Accounts payable 1,368us-gaap_IncreaseDecreaseInAccountsPayable (60)us-gaap_IncreaseDecreaseInAccountsPayable
Accrued expenses 299us-gaap_IncreaseDecreaseInAccruedLiabilities (497)us-gaap_IncreaseDecreaseInAccruedLiabilities
Deferred revenue (966)us-gaap_IncreaseDecreaseInDeferredRevenue (966)us-gaap_IncreaseDecreaseInDeferredRevenue
Income taxes payable 332us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable (70)us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable
Net cash provided by operating activities 6,849us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 1,437us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash Flows from Investing Activities    
Proceeds from sale 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 18us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
Purchase of property and equipment (821)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (800)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Acquisition of Sterimedix Limited (13,177)us-gaap_PaymentsToAcquireBusinessesGross 0us-gaap_PaymentsToAcquireBusinessesGross
Acquisition of patents and other intangibles (167)us-gaap_PaymentsToAcquireIntangibleAssets (229)us-gaap_PaymentsToAcquireIntangibleAssets
Net cash used in investing activities (14,165)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (1,011)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash Flows from Financing Activities    
Deferred financing costs (102)us-gaap_PaymentsOfFinancingCosts 0us-gaap_PaymentsOfFinancingCosts
Proceeds from borrowings under the Term Loan Facility 2,750us-gaap_ProceedsFromIssuanceOfLongTermDebt 0us-gaap_ProceedsFromIssuanceOfLongTermDebt
Principal payment on Term Loan facility (137)us-gaap_RepaymentsOfLinesOfCredit 0us-gaap_RepaymentsOfLinesOfCredit
Proceeds from the issuance of common stock 28us-gaap_ProceedsFromIssuanceOfCommonStock 36us-gaap_ProceedsFromIssuanceOfCommonStock
Tax benefit associated with the exercise of non-qualified stock options 28us-gaap_DeferredTaxExpenseFromStockOptionsExercised 25us-gaap_DeferredTaxExpenseFromStockOptionsExercised
Net cash provided by financing activities 2,567us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 61us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Foreign exchange rate effect on cash and cash equivalents (246)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (204)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net (decrease) increase in cash and cash equivalents (4,995)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 283us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents    
Beginning 15,443us-gaap_CashAndCashEquivalentsAtCarryingValue 12,470us-gaap_CashAndCashEquivalentsAtCarryingValue
Ending $ 10,448us-gaap_CashAndCashEquivalentsAtCarryingValue $ 12,753us-gaap_CashAndCashEquivalentsAtCarryingValue